CH BIOTECH SER 08037Hong Kong Stock Exchange

0.5053.81%( -0.020 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
CH BIOTECH SER (08037) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX GEM
Listing Date
2004-06-17
Industry
Healthcare Services
Fiscal Year End
Dec 31
ISIN
BMG2152F1014

Industry

Healthcare Services 1.31%
61 stocks in this industry
Down 15 Up 29
Industry RankingsValue (HKD)Rank
Revenue (Last FY)66.39M52/57
Net Profit (Last FY)-62.12M47/57
ROE (Last FY)-35.93%57/63

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Liu Xiaolin Executive Director
Huang Song Executive Director
Yin Ye Executive Director
Yan Guoxiang Independent Non-Executive Director
Guo Yuantao Independent Non-Executive Director
Zhang Xiao Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-05-04.

About this page

This page shows CH BIOTECH SER (08037) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.